FDA orphan drugs staff
Executive Summary
Former Center for Biologics Evaluation & Research Office of Cellular, Tissue & Gene Therapies Acting Director Phil Noguchi, MD, joins Office of Orphan Products Development as medical reviewer. Joyce Frey-Vasconcells assumes acting director post at CBER's cell therapies office...